⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1958756 | 0.81 | ALDH1A1 (1.00) | — | |
| SCHEMBL1332089 | 0.81 | — | — | |
| SCHEMBL3673 | 0.81 | — | — | |
| SCHEMBL1694475 | 0.79 | ALDH1A1 (0.50) | — | |
| SCHEMBL2716711 | 0.78 | — | — | |
| SCHEMBL774596 | 0.78 | — | — | |
| Methane SCHEMBL1901030 | 0.78 | — | — | |
| SCHEMBL544742 | 0.78 | — | — | |
| Water SCHEMBL22362219 | 0.78 | — | — | |
| Bromide SCHEMBL10459370 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1196631-A1 | POLYNUCLEOTIDES | Cyclops Genome Sciences Limited (GB) | 2002-04-17 | — | — | EP | claimed |
| WO-2001094626-A1 | POLYNUCLEOTIDES | CYCLOPS GENOME SCIENCES LIMITED (GB) | 2001-12-13 | — | — | WO | claimed |
| WO-2000075306-A2 | METHOD FOR PRODUCING DOUBLE STRANDED POLYNUCLEOTIDES | CYCLOPS GENOME SCIENCES LIMITED (GB) | 2000-12-14 | — | — | WO | claimed |
| WO-2000066605-A2 | POLYNUCLEOTIDES | CYCLOPS GENOME SCIENCES LIMITED (GB) | 2000-11-09 | — | — | WO | claimed |
| CN-114751920-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-114736219-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118139851-A | Antitumor compounds | 法马马有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117865987-A | Antitumor compounds | 法马马有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-114615999-B | Drug antibody conjugates | 法马马有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-110650954-B | anticancer compounds | 法马马有限公司 | 2023-11-03 | — | — | CN | disclosed |
| US-20230104690-A1 | MATRIX METALLOPROTEINASE INHIBITORS (MMPIs) | BRANDON UNIV (CA) | 2023-04-06 | — | — | US | disclosed |
| CN-113226377-B | Antibody drug conjugates comprising an eltrinastine derivative | 法马马有限公司 | 2022-10-18 | — | — | CN | disclosed |
| WO-2000041505-A2 | ANTHRANILIC ACID DERIVATIVES | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042003-A1 | BENZENESULFONAMIDE DERIVATIVES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042022-A1 | BENZOHETEROCYCLES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042029-A1 | 1-HETEROCYCLE SUBSTITUTED DIARYLAMINES | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000041994-A1 | 4-ARYLAMINO, 4-ARYLOXY, AND 4-ARYLTHIO DIARYLAMINES AND DERIVATIVES THEREOF AS SELECTIVE MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| WO-2000042002-A1 | SULPHOHYDROXAMIC ACIDS AND SULPHOHYDROXAMATES AND THEIR USE AS MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| EP-0975632-A1 | ALKALOID HALIDE SALTS OF SWAINSONINE AND METHODS OF USE | Glycodesign Inc. (CA) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998046602-A1 | ALKALOID HALIDE SALTS OF SWAINSONINE AND METHODS OF USE | GLYCODESIGN INC. (CA) | 1998-10-22 | — | — | WO | disclosed |